Fmoc-Lys(ivDde)-OH: A Key Building Block for Peptide Synthesis and Drug Discovery
Unlock the potential of advanced peptide synthesis with this specialized amino acid derivative.
Get a Quote & SampleProduct Core Value
Fmoc-Lys(ivDde)-OH
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine is a highly specialized amino acid derivative essential for modern peptide synthesis and cutting-edge drug development.
- Leverage Fmoc-Lys(ivDde)-OH for enhanced peptide stability and solubility in your drug development projects.
- Facilitate the creation of complex peptide sequences with high purity and yield using this critical building block for peptide synthesis.
- Explore its utility in the development of peptide-based therapeutics for diseases like cancer, a key area of medicinal chemistry research.
- Utilize this versatile amino acid derivative in bioconjugation processes for improved functionality in drug delivery systems.
Advantages Provided by the Product
Enhanced Peptide Synthesis Purity
Achieve superior purity in your synthesized peptides, a critical factor for drug discovery amino acid support.
Improved Therapeutic Efficacy
Contribute to the development of effective peptide-based therapeutics by incorporating this advanced amino acid derivative.
Streamlined Bioconjugation
Simplify bioconjugation chemistry innovations by using a reliable lysine derivative for enhanced molecular linking.
Key Applications
Peptide Synthesis
Serve as a crucial building block for creating complex peptide sequences, supporting advanced peptide synthesis reagent needs.
Drug Development
Play a significant role in designing peptide-based therapeutics that target specific diseases, aiding medicinal chemistry building blocks.
Bioconjugation
Facilitate the attachment of biomolecules to surfaces or other molecules, essential for advanced drug delivery system design.
Cancer Therapy Research
Explore potential in cancer research by modifying peptides for enhanced efficacy against tumor cells, supporting oncology peptide drug research.